Wagstaff, J., Maio, M., Schöffski, P., Carlino, M. S., Lebbé, C., McArthur, G., . . . Wolchok, J. D. (2019). Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. New England Journal of Medicine, 381(16), pp. 1535-1546. doi:10.1056/nejmoa1910836
Chicago Style CitationWagstaff, John, et al. "Five-Year Survival With Combined Nivolumab and Ipilimumab in Advanced Melanoma." New England Journal of Medicine 381, no. 16 (2019): 1535-1546.
MLA CitationWagstaff, John, et al. "Five-Year Survival With Combined Nivolumab and Ipilimumab in Advanced Melanoma." New England Journal of Medicine 381.16 (2019): 1535-1546.
Warning: These citations may not always be 100% accurate.